http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-0721131-D0
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8cf2caf35a4f97a4534d8923f7fd25a4 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004 |
| filingDate | 2007-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-0721131-D0 |
| titleOfInvention | "Peptide and users thereof" |
| abstract | The invention relates to fragments of Chromogranin A (CgA) derived peptide fragments and their use in methods of therapy, for example in the treatment of diabetes etc. The peptides, for example AL-11, GV-19 and WE-14, are tropic, i.e stimulate release of regulatory substances and may be used in the absence of a stimulatory concentration of glucose. |
| priorityDate | 2007-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.